Meet the experts who feature throughout the CSU Learning Zone
Dr Alexander Eggel. Principal investigator at the Department of Rheumatology, Immunology and Allergy at the University of Bern, Switzlerland. His major research interests include the biological mechanisms underlying both beneficial and pathologic type 2 immune responses.
Dr Ana Giménez-Arnau. Associate Professor of Dermatology at the Universitat Autònoma and Pompeu Fabra of Barcelona and consultant Physician in Dermatology and Venereology in the Department of Dermatology at the Hospital del Mar.
Dr Désirée Larenas-Linnemann. Director of the Centre for Excellence in Asthma and Allergy at the Hospital Médica Sur in Mexico City. She has been responsible for coordinating a number of guideline activities and was an expert panel member of the EAACI/GA2LEN/EDF/WAO urticaria guideline update in 2017. She has over 150 articles published in peer-reviewed journals.
Professor Elias Toubi. Director of the Allergy and Clinical Immunology Department, Bnai Zion Medical Centre in Haifa, Israel. Professor Toubi has a number of research interests including autoimmunity and immune-regulatory mechanisms, i.e., B-regulatory cells.
He is a member of international allergy associations such as the GA2LEN board and active in organising International Schools for Urticaria for young fellows under the supervision of GA2LEN.
Dr John Reed. Clinical Lead and Consultant Dermatologist at the Oxford University Hospitals NHS Foundation Trust in Oxford and Banbury, Oxfordshire, UK. Dr Reed has also been an honorary senior lecturer in Oxford since 2007.
Professor Marcus Maurer. Professor of Dermatology and Allergy at the Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany. He is also the Director of Research at the Department of Dermatology and Allergy, Associate Director of the Allergie-Centrum-Charité, and Head of the Specialty Clinics for angioedema, hereditary angioedema, urticaria, mastocytosis, pruritus, auto-inflammatory disorders, and the Dermatological Allergology Laboratory.
Professor Martin Metz. Professor of Dermatology at the Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany. His main scientific areas of interest are mast cell biology, neuroimmunology, inflammation and innate immunity, the major clinical focus is on pruritus and mast cell mediated diseases.
Dr Sarbjit Saini. Associate Professor of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Mayland, USA. Dr Saini is a fellow of the American Academy of Allergy, Asthma and Immunology (AAAAI) and diplomate of the American Board of Allergy and Immunology.
Dr Zuatao Zhao. Associate Professor at the Department of Dermatology, Peking University, First Hospital in Beijing, China. Dr Zhao is Director of the GA2LEN UCARE in China and a member of many scientific societies. He is chairman of the Allergy League in China and founder of the Chinese Allergy College. Among other things, he is also Director of the Multidisciplinary Teamwork Allergy at First Hospital.
CSU Resources and Managing CSU have been developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
The industry-sponsored symposia and eLearning have been developed in collaboration with Novartis Pharma AG, with some content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Any data on non- Novartis products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country.